Wave Life Sciences (WVE) Net Cash Flow Growth (5y) (2019 - 2026)
Wave Life Sciences (WVE) Net Cash Flow Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Wave Life Sciences | 1.22 Bn | 672.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.90% |
| Dec 31, 2025 | 71.19% |
| Sep 30, 2025 | -16.00% |
| Jun 30, 2025 | -5.18% |
| Mar 31, 2025 | -17.63% |
| Dec 31, 2024 | 32.36% |
| Sep 30, 2024 | 41.01% |
| Jun 30, 2024 | 4.98% |
| Mar 31, 2024 | -16.78% |
| Dec 31, 2023 | 29.87% |
| Sep 30, 2023 | -1.22% |
| Jun 30, 2023 | -17.82% |
| Mar 31, 2023 | 41.87% |
| Dec 31, 2022 | 20.10% |
| Sep 30, 2022 | 2.03% |
| Jun 30, 2022 | -1.93% |
| Mar 31, 2022 | -33.59% |
| Dec 31, 2021 | 29.66% |
| Sep 30, 2021 | -9.05% |
| Jun 30, 2021 | -16.71% |